SOUTH SAN FRANCISCO, CA — (Marketwire) — 01/22/13 — VistaGen Therapeutics, Inc. (OTCBB: VSTA) (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism screening, today announced that Shawn K. Singh, CEO of VistaGen, will present at Noble Financial Capital Markets- Ninth Annual Equity Conference.Mr. Singh will discuss VistaGen-s progress and unique opportunities to apply its stem cell technology platform, Human Clinical Tr
